No Detail Found!

Design, Synthesis and Biological Evaluation of Dual Acetyl Cholinesterase and Beta-secretase Inhibitors in Treatment for Alzheimer's Disease.

Author(s)
Youchao Deng Department of Pharmaceutical Engineering, College of Chemistry and Chemical Engineering, Central South University, Changsha, PR China
Yuren Jiang Department of Pharmaceutical Engineering, College of Chemistry and Chemical Engineering, Central South University, Changsha, PR China
Xiongjie Zhao Department of Pharmaceutical Engineering, College of Chemistry and Chemical Engineering, Central South University, Changsha, PR China
Jinlian Wang Department of Pharmaceutical Engineering, College of Chemistry and Chemical Engineering, Central South University, Changsha, PR China
Abstract
With the recent research advances in molecular biology and technology multiple credible hypotheses about the progress of Alzheimer's disease (AD) have been proposed, among which the amyloid and cholinergic hypotheses are commonly used to develop reliable therapeutic agents. The multitarget-directed ligand (MTDL) approach was taken in this work to develop muilti-functional agents, which can mainly serve as dual beta-secretase (BACE 1) and Acetylcholinesterase (AChE) inhibitors. Series of new compounds were designed, synthesized and evaluated in this work, from which we identified 2-((4-(1,3-dioxoisoindolin-2-yl)benzyl)amino)-2-oxoethyl-2-(4-methoxyphenyl)acetate (1h) as a new dual cholinesterase and beta-secretase inhibitor without toxicity.
Publication Details
Page(s) 2091-2098
DOI DOI not available
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 32, Issue: 5, Year: 2019

Request the full text from PASTIC

Keywords
Alzheimer's Disease
0

Citations

0

Downloads

61

Views